On July 23, BlackRock’s spot ETFs made major purchases, acquiring 1,190 Bitcoin (BTC) and 86,650 Ethereum (ETH). This move highlights strong institutional confidence in leading cryptocurrencies amid active market conditions. The increased holdings reflect growing investor demand for exposure to digital assets through reputable ETF products. BlackRock’s continued investment emphasises its influential role in driving institutional participation in the evolving cryptocurrency market.
Bitcoin price rallied 10% as Trump hinted at a tariff rollback, boosting risk appetite. However, market uncertainty persists, as analyst spots patterns similar to 2019’s US trade war impact.
Bitcoin (BTC) Rally Restarts as Trump Hints at Tariff U-Turn
Bitcoin (BTC) volatility persisted on Wednesday as traders reacted to fresh developments in U.S. trade policy.
Since President Donald Trump announced the creation of a Crypto Strategic Reserve on Sunday, March 2, BTC has traded within 10% ranges for three consecutive days.
After surging 11% following the strategic reserve announcement, Bitcoin’s rally was abruptly halted when Trump confirmed a 25% import tariff on Canada and Mexico, triggering a sharp 15% sell-off on Monday. However, the market took another dramatic turn on Wednesday.
Late Tuesday, U.S. Secretary of Commerce Howard Lutnick stated that President Trump will “probably” reach a compromise with Canada and Mexico in the coming days. Traders responded swiftly, piling into buy orders on optimism that an anticipated tariff rollback could ease economic uncertainty, bolstering risk assets like Bitcoin.
Bitcoin (BTC) Price Action, March 5
Within 12 hours of Lutnick’s statement, BTC surged 10%, rallying from its weekly low of $81,400 recorded on Tuesday to reclaim levels above $91,500 by mid-day in U.S. trading. If bullish momentum holds, a close above $90,000 could reinforce a broader breakout attempt, setting the stage for Bitcoin to target new highs.
Lance Roberts flags Trade war reactions exerting bearish pressure on BTC price action
On Wednesday, BTC price reclaimed territories above the $91,500 level as markets reacted to speculations that US President Donald Trump could ease tariffs imposed on Canada and Mexico.
Bitcoin analyst Lance Roberts published charts showing how US Trade policy has impacted financial markets in recent weeks.
“Trade War 1 vs Trade War 2.
So far, the #market is tracing out Trump’s first trade war fairly closely. While no two markets are ever the same, it is worth noting that even though markets declined, they also rallied. The point here is to ignore media headlines and focus on your portfolio.”
Diving into the chart he posted, Lance Roberts’ chart draws a striking parallel between the S&P 500’s performance during the 2019 trade war and its 2025 trajectory, illustrating how historical market reactions to U.S. trade tensions could be playing out again.
S&P 500 Futures Price Action: 2025 YTD vs. 2019 Trade War | Source: https://x.com/LanceRoberts
In 2019, the market initially rallied before experiencing volatility tied to major trade-related developments.
One key moment highlighted in the chart is when former President Trump called off 25% tariffs on Mexico, triggering a strong rally.
Later, news of Trump-Xi trade deal talks fueled further gains, reinforcing the notion of a “Trump put”—the market’s expectation that
Trump would eventually ease trade tensions to support equities. This de facto put acted as a backstop, preventing prolonged downturns despite interim sell-offs. So far in 2025, the S&P 500 has followed a similar script, with a strong start before recent weakness, aligning with the early phases of the 2019 pattern.
This suggests that while the market is experiencing turbulence amid trade concerns, a potential bullish pivot could occur if Trump signals a shift in policy, just as it did in 2019. If history rhymes, Bitcoin could benefit as a risk asset.
BTC Price Outlook on US Trade War
However, the bearish case remains compelling. Unlike in 2019, today’s market is contending with structurally higher interest rates, which could dampen any relief rallies. Additionally, the Federal Reserve’s policy stance is less accommodative, meaning liquidity injections that cushioned past downturns may not materialize.
Ultimately, whether the 2019 pattern continues to play out in full will depend on the next moves from policymakers.
If trade tensions escalate further without policy relief and risk appetite deteriorates, BTC’s recent gains may prove short-lived, exposing the market to deeper corrections.
Conversely, if Trump eases the tariffs this week, both S&P 500 equities and Bitcoin price could be poised for another leg higher. In this case BTC price could hit new all-time highs near $120,000 once US Treasury begins buying BTC and other assets included in the crypto strategic reserve bucket.
Bitcoin Technical Analysis Today: Close above $90,000 could spark support $100K breakout prospects
Technical indicators on the 12-hour Bitcoin price forecast chart below suggest a close above the $90,000 could confirm a bullish shift in market momentum, especially if Trump officially rolls back the tariffs as widely anticipated.
BTC price has rebounded sharply, gaining 11.46% over the past 24 hours, signaling a resurgence in buyer confidence. The bullish momentum coincides with Bitcoin breaking out of the lower Keltner Channel (KC) boundary, historically a precursor to sustained rallies.
A confirmed move past $90,000 could see the upper KC boundary at $97,487 tested, with $100,000 becoming a psychological magnet if bullish momentum persists.
Bitcoin Price Forecast (BTCUSD) | March 5
However, the Parabolic SAR remains positioned above price action, indicating that downward pressure has yet to be fully negated.
A failure to hold above $88,000 support could see a retracement toward the mid-KC line at $80,210, where buyers may attempt to reestablish control.
Meanwhile, the Bull-Bear Power (BBP) has flipped positive after a prolonged period in the red, reinforcing short-term bullish sentiment.
If BBP sustains its uptrend, further upside pressure could validate the bullish thesis. On the contrary, a sudden reversal in BBP, coupled with rejection at $90,000, might expose Bitcoin to another wave of selling.
By Ayelet Richter, Business Development Expert and AI Business Consultant
The technological and industrial revolutions have always worked hand in hand. The breakneck speed at which technology is evolving today is contributing to consistent breakthroughs, especially in the areas of health and finance. As innovators in the tech and healthcare space deftly navigate the complexities of transforming industries, the investment landscape also begins to shift. The obvious similarities between cryptocurrency and AI are opening the door for wild potential in the future and enhancing opportunities for investors.
Advancements and challenges in the AI revolution
While artificial intelligence (AI) is not a new discovery, its role in the healthcare space is novel. AI is revolutionizing spaces such as drug discovery and drug development, data collection and interpretation, and efficiency improvement in all areas of the pharma industry. AI-driven solutions are still in their relative infancy for healthcare applications, but their potential is already crystal clear concerning improving efficiency, reducing failure rates, and accelerating the time-to-market for new drugs.
Integrating AI technology into the pharma sector can be a complex undertaking, presenting several challenges for those on the front lines of AI innovation. Regulatory and compliance guidelines have not always kept pace with discovery, leading to unnecessary hurdles in the rollout of new drugs and processes. Data availability, quality, and security may be lacking. Pharmaceutical data is often fragmented across different institutions, creating accessibility barriers. Data privacy regulations like HIPAA and GDPR also limit the availability of real-world patient data for AI training. This is where blockchain technology can assist the emergence of effective AI in healthcare. By leveraging federated learning, AI models can be trained across decentralized data sources without compromising privacy.
Investment in AI models can also be met with skepticism. Many AI models function as black boxes, making it difficult for regulators and pharma executives to trust their recommendations. Lack of interpretability in AI-driven drug discovery models can create distrust in clinical and regulatory environments.
Cost is a significant barrier to AI implementation in healthcare. AI integration requires substantial investment in infrastructure, talent acquisition, and computational power. Training AI models on biomedical data is expensive and requires access to cloud computing resources, GPUs, and specialized algorithms. Pharma companies may hesitate to invest in AI without immediate financial returns. To combat this issue, many are turning to cost-effective AI-as-a-Service (AIaaS) models, allowing pharma companies to use AI solutions without massive upfront investment, exploring public-private partnerships, and grant funding to support AI-driven research in pharma, or leveraging pre-trained AI models and transfer learning techniques to reduce training costs.
Crypto investment and AI
With AI poised to redefine the healthcare landscape, it is no wonder cryptocurrency investors have a keen interest in the technology. The interwoven nature of blockchain technology and healthcare AI applications for security and efficiency appeals to the burgeoning crypto market. While overcoming the mentioned challenges in AI integration will be critical for market application success, catering to the investment interests of crypto investors will also be significant in the overall adoption of AI in the pharma space.
Advancements in AI in the pharma sector have led to an uptick in venture capital investment, strengthening the trust muscle of other interested parties, such as crypto investors. According to a recent study, 38% of new investment dollars allocated for healthcare are directed towards AI-enabled technologies. The validity of AI partnerships and the necessity of AI assistance in pharma development and discovery efficiency have driven investment. The convergence of AI and cryptocurrency is already emerging through crypto, such as AxonDAO ($AXGT) and Welshare Health ($WEL), creating opportunities for crypto investors to enter the space.
The currently available advancements of AI in the pharma sector are just the tip of the iceberg. Investors should be aware of the exponential growth potential in healthcare AI. As innovators navigate the myriad of hurdles on the pathway to full adoption — such as regulatory matters and investor skepticism — they continue to make welcomed advancements in the space. Crypto investors are likely to play a crucial role in the future adoption of AI in healthcare. As investor trust in AI in the pharma space b
The post Investments in AI: Revolutionizing the Pharmaceutical Industry’s Future appeared first on Coinpedia Fintech News
By Ayelet Richter, Business Development Expert and AI Business Consultant The technological and industrial revolutions have always worked hand in hand. The breakneck speed at which technology is evolving today is contributing to consistent breakthroughs, especially in the areas of health and finance. As innovators in the tech and healthcare space deftly navigate the complexities …
Popular altcoin Solana has shed nearly 10% of its value over the past week, and the bearish pressure does not appear to be letting up. The token dropped to $129 today, as geopolitical tensions between the US and Iran escalate.
As the second quarter of 2025 draws to a close, mounting selloffs have placed Solana’s price at risk of breaking below the crucial $130 support level. This analysis explains how.
SOL Slips as Key Indicators Remain Bearish
Over the past seven days, SOL’s price has steadily declined. This has been accompanied by a dip in the coin’s Chaikin Money Flow (CMF), which has fallen deeper into negative territory. As of this writing, SOL’s CMF is at -0.13.
The CMF measures the flow of money into and out of an asset over a specific period, typically 20 or 21 days. It combines price and volume data to assess buying and selling pressure. When an asset’s CMF is positive, buying volume is dominant and capital is flowing into the asset, indicating potential bullish sentiment.
Conversely, when the CMF turns negative, selling volume outweighs buying volume, meaning money flows out. This signals weakening demand for SOL, especially if the negative reading deepens while price declines.
Moreover, the coin’s Elder-Ray Index, which gauges the balance between buyers and sellers, is at -20.74, signifying that sellers are firmly in control.
This indicator measures the strength of bulls and bears in the market by analyzing the difference between an asset’s price and a moving average. When it is negative, bears dominate, as prices consistently fall below the average, suggesting selling pressure outweighs buying interest.
Will SOL Recover Above $130 or Is a Drop to $123 Looming?
This bear dominance reflects the growing conviction that SOL’s price could decline further, particularly if $134 fails to hold as a support floor.
Meanwhile, a breakdown below this level could open the door for deeper losses, potentially dragging SOL toward $123.49.
